Company GeneNews Ltd Toronto S.E.
Equities
CA36870T2065
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Clinical Consultation
79.7
%
| - | - | 4 | 79.7 % | - |
Laboratory Testing
20.3
%
| - | - | 1 | 20.3 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
70.0
%
| - | - | 3 | 70.0 % | - |
Western Europe
30.0
%
| - | - | 1 | 30.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01-12-31 | |
Rebecca Greco
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 97-12-31 |
Garth MacRae
BRD | Director/Board Member | 90 | 99-12-31 |
Chief Executive Officer | - | 01-12-31 | |
Harry Glorikian
BRD | Director/Board Member | 58 | 08-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 123,532,981 | 98,370,853 ( 79.63 %) | 0 | 79.63 % |
Company contact information
StageZero Life Sciences Ltd.
70 East Beaver Creek Road Unit 30
L4B 3B2, Richmond Hill
+
http://www.stagezerolifesciences.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |